If they're marketing their own drug (as implied by other comments - I don't know), you might also ask what stops them from running the studio on a 100 groups of

If they're marketing their own drug (as implied by other comments - I don't know), you might also ask what stops them from running the studio on a 100 groups of 40 patients, and picking the "best" for publication... (other than ethics, obviously)...